This paper is in the following e-collection/theme issue:
RCTs - Protocols/Proposals (eHealth) (668) Obstetrics, Gynecology, and Reproductive Medicine (329) Pregnancy Information, Education and Lifestyle Interventions (400)Published on in Vol 11, No 10 (2022): October
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/37452, first published
.

The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial
The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial
Authors of this article:
Pablo Garcia-Manau1
;
Manel Mendoza1
;
Erika Bonacina1
;
Raquel Martin-Alonso2, 3
;
Lourdes Martin4
;
Ana Palacios5, 6
;
Maria Luisa Sanchez7
;
Cristina Lesmes8
;
Ivan Hurtado9
;
Esther Perez10
;
Albert Tubau11
;
Patricia Ibañez12
;
Marina Alcoz13
;
Nuria Valiño14
;
Elena Moreno15
;
Carlota Borrero16
;
Esperanza Garcia17
;
Eva Lopez-Quesada18
;
Sonia Diaz19
;
Jose Roman Broullon20
;
Mireia Teixidor21
;
Carolina Chulilla22
;
Maria M Gil2, 3
;
Monica Lopez4
;
Amparo Candela-Hidalgo5, 6
;
Andrea Salinas-Amoros7
;
Anna Moreno8
;
Francesca Morra9
;
Oscar Vaquerizo10
;
Beatriz Soriano11
;
Marta Fabre12
;
Elena Gomez-Valencia13
;
Ana Cuiña14
;
Nicolas Alayon15
;
Jose Antonio Sainz16
;
Angels Vives17
;
Esther Esteve18
;
Vanesa Ocaña19
;
Miguel Ángel López20
;
Anna Maroto21
;
Elena Carreras1
There are currently no tweets available for this article within the specified range.